亚临床甲亢对2型糖尿病患者不良心血管事件的影响
[Abstract]:Objective To study the effect of subclinical hyperthyroidism on adverse cardiovascular events in patients with type 2 diabetes mellitus (T2DM). Methods 561 patients with T2DM were selected,61 cases of subclinical hyperthyroidism and 465 cases of normal thyroid function were diagnosed. All patients were followed for an average of 5 years to review the thyroid function and to observe the outcome of subclinical hyperthyroidism at the end of follow-up; to evaluate the occurrence of adverse cardiovascular events (including coronary events, new AF, all-cause death) in subclinical hyperthyroidism and normal thyroid function. The independent risk factors of coronary events in patients with T2DM with subclinical hyperthyroidism were analyzed by multi-factor regression model. Results Among the 61 patients with subclinical hyperthyroidism,41 cases of subclinical hyperthyroidism,5 cases of clinical hyperthyroidism,13 cases of normal thyroid function and 2 cases of death were still performed at the end of follow-up, and in the patients with normal thyroid function at the time of admission, the thyroid function was normal in 453 cases at the end of follow-up. 12 cases died. At the end of the follow-up,11 patients (26.8%),4 (9.8%) of new AF, and 453 patients with normal thyroid function had coronary events (7.9%) and 10 (2.2%) of new AF. The incidence of new AF in patients with subclinical hyperthyroidism was higher than that of normal thyroid function (P 0.01 and 0.05). The incidence of coronary events was higher in patients with T2DM with a history of hypertension and coronary heart disease, a history of hypertension and coronary heart disease, a fasting blood glucose of 7.0 mmol/ L and a combination of HbA _ (1c) and 7.0 mmol/ L in subclinical hyperthyroidism. Multiple factor regression, subclinical hyperthyroidism, HbA _ (1c) level, history of coronary heart disease and age were independent predictors of coronary events in the patients with T2DM (P <0.05). Conclusion Subclinical hyperthyroidism is an independent risk factor of adverse cardiovascular events in patients with T2DM, which can lead to coronary events and the incidence of new AF is increased.
【作者单位】: 南京医科大学附属淮安第一医院;
【分类号】:R587.1;R581.1
【相似文献】
中国期刊全文数据库 前10条
1 李新禾;;亚临床甲亢108例临床分析[J];实用糖尿病杂志;2007年05期
2 罗薇;;亚临床甲亢伴低血钾麻痹27例临床分析[J];浙江实用医学;2008年01期
3 刘志梅;亚临床甲状腺功能亢进症的随访分析[J];临床医学;2004年11期
4 郭爱群,唐荣德,冯国新,张冠新;甲亢和亚临床甲亢患者血细胞分析的结果比较[J];蛇志;2004年04期
5 汤建林,赵立群,李玉莹,汪慧如,杨丽秋;亚临床甲状腺功能亢进症73例分析[J];中国误诊学杂志;2004年12期
6 袁济民,朱翠英,崔文儒;TSH(IRMA)测定的临床应用及其评价[J];核技术;1993年05期
7 唐荣德,冯国新,刘社炎,张冠新,郭爱群;亚临床甲亢和甲减发病的实验室调查(英文)[J];蛇志;2003年04期
8 陈威,崇巍,单忠艳,李玉姝,关海霞,范晨玲,滕卫平;甲状腺刺激性抗体、碘摄入量与亚临床甲亢发病及预后的关系[J];中国免疫学杂志;2005年09期
9 李澜,樊彩霞,代洁;老年亚临床甲状腺功能亢进症36例分析[J];中国误诊学杂志;2005年01期
10 王济芳;陈军建;杨玲;;亚临床甲状腺功能亢进症转归临床分析[J];中国现代药物应用;2008年04期
中国重要会议论文全文数据库 前7条
1 李佳;陈彦彦;滕卫平;单忠艳;王薇薇;范晨玲;陈威;满娜;;血清甲状腺刺激性抗体对甲状腺功能亢进症患者发病及转归的影响[A];2008内分泌代谢性疾病系列研讨会暨中青年英文论坛论文汇编[C];2008年
2 涂晓坤;陈如泉;;亚临床甲亢100例临床分析[A];中华医学会第十一次全国内分泌学学术会议论文汇编[C];2012年
3 王民登;韦华;;亚临床甲亢骨代谢状况临床研究[A];全国中西医结合内分泌代谢病学术会议论文汇编[C];2006年
4 夏树剑;;亚临床甲亢并周期性瘫痪的临床分析[A];2007年浙江省神经病学学术年会论文汇编[C];2007年
5 杜馥曼;杨玉芝;向朝峰;江红;王丹;;小剂量甲巯咪唑治疗亚临床甲亢合并阵发性房颤的临床观察[A];中华医学会第十次全国内分泌学学术会议论文汇编[C];2011年
6 赵秀云;;糖尿病患者甲状腺功能异常筛查的意义[A];创新驱动,加快战略性新兴产业发展——吉林省第七届科学技术学术年会论文集(下)[C];2012年
7 杨玉芝;冯琨;刘余;许丽娟;樊蕾;;黑龙江地区2型糖尿病共患自身免疫性甲状腺疾病的临床调查[A];中华医学会第十二次全国内分泌学学术会议论文汇编[C];2013年
中国重要报纸全文数据库 前1条
1 王雪飞邋孙扬;甲减发病率高于甲亢[N];健康报;2007年
中国博士学位论文全文数据库 前2条
1 张海三;Graves病患者~(131)Ⅰ治疗前后氧化应激状态、生存质量及临床疗效评价[D];郑州大学;2014年
2 杨利波;促甲状腺激素与心血管事件关系的研究[D];山东大学;2013年
中国硕士学位论文全文数据库 前3条
1 许千;亚临床甲状腺功能亢进症的研究进展[D];河北医科大学;2010年
2 张曦月;不同剂量复方甲亢片对甲亢缓解期亚临床甲亢疗效影响的临床观察[D];湖北中医学院;2008年
3 王平;复方甲亢片治疗气阴两虚型亚临床甲亢状态的临床观察[D];湖北中医药大学;2012年
,本文编号:2498167
本文链接:https://www.wllwen.com/yixuelunwen/nfm/2498167.html